维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="LOX C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
2	Exercise as an intervention for enhancing subjective well'being in an HIV- I Population显示文摘	LOX C L McAULEY E TUCKER R S	1995	JSEP1995，17，4：	1
3	Determination of the serum matrix metalloproteinase-9(MMP-9) and tissue inhibitor of matrix metalloproteinase-1(TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
4	Evaluation of an aquatics programme on fitness parameters of individuals with a brain injury显示文摘	Driver S O'connor J Lox C	2004	Brain Inj2004，18，9：	1
5	Determination of the serum matrix metallop- roteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatmen显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，：	1
6	Evaluation of an aquat-ics programme on fitness parameters of individuals with abrain injury显示文摘	Driver S O'connor J Lox C	2004	Brain Inj2004，18，9：	1
7	Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung eaneer or non-small-cell lung eaneer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
8	Determination of the serum matrixmetallo-proteinase-9(MMP-9)and tissue inhibitor of matrix metalloproteinase-1(TIMP-1)in patientswith either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，：	1
9	Investigation on the use of neck skin for microbi-al process control of fresh poultry meat with the ATP biolumdn^cence meth-od 显示文摘	ELLERBROEK L LOX C	2004	Deutsche Tierarztliche Wochenschrift2004，111，5：	1
10	Determination of the serum matrix metalloproteinase-9(MMP-9) and tissue inhibitor of matrix metalloproteinase-1(TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Cobos E Lox C	2004	Respir Med2004，98，：	1
11	Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metallopruteinase-1 ( TIMP-1 ) in patients with either advanced small-cell lung eancer or non-small-cell lung cancer prior to treatment 显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
12	Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
13	Long-term maintenance of exercise, self-efficacy, and physiological change in older aduhs显示文摘	MCAULEY E LOX C DUNCAN T E	1993	Journal of gerontology1993，48，4：	1
14	Determination of the Serum matrix- metallo-proteinase-9 (MMP-9) and tissue inhibitor of matrix metallo- proteinase-1 (TIMP-1) in patients with either advanced small-cell tung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2008	Respir Med2008，98，：	1
15	Evaluation of an aquatics programme on fitness parameters of individuals with a brain injury显示文摘	Driver S O'connor J Lox C	2004	Brain Inj2004，18，9：	1
16	HDL-associated LP-PLA2 reduces endothelial adhesiveness in apoE-/mice显示文摘	Theilmeier G De Geest B Van Veldhoven PP Stengel D Michiels C Lox M	2000	FASEB J2000，14，13：	1
17	Revisiting the Measurement of Exercise Induced Feeling States:the Physical Activity Affect Scale (PAAS)显示文摘	LOX C L JACKSON S TUHOLSKI S W	2000	Measurement Phy Edu Exe Sci2000，，：	1
18	Determination of the serum matrix metalloproteirase-9(MMP-9) and tissue inhibitor of matrix metalloproteinase-1(TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1
19	The circulating urokinase plasminogen activator (uPA) and its soluble receptor (suPAR) are not up-regulated by the circulating P105 fraction of the HER-2/neu proto-oncogene: in vivo evidence from patients with advanced non-small cell lung cancer (NSCLC) 显示文摘	Cobos E Lox C	2002	Anticancer Res2002，22，：	1
20	Determination of the serum matrix metalloprotei-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-smal-cell lung cancer prior to treatment显示文摘	Jumper C Cobos E Lox C	2004	Respir Med2004，98，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示